GYRE THERAPEUTICS, INC. Earnings Per Share Diluted

Quick Answer

GYRE THERAPEUTICS, INC. reported Earnings Per Share Diluted of $0.02 per share for the year ending 2025.

  • GYRE THERAPEUTICS, INC. showed a decrease of -60.0% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from GYRE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2009 to 2025), GYRE THERAPEUTICS, INC.'s Earnings Per Share Diluted has grown by 101.3%.
  • Historical annual values: Fiscal year 2025: $0.02 per share | Fiscal year 2024: $0.05 per share | Fiscal year 2023: $1.41 (loss) per share | Fiscal year 2022: $0.03 per share | Fiscal year 2021: $2.87 (loss) per share | Fiscal year 2012: $0.21 (loss) per share | Fiscal year 2011: $0.27 (loss) per share | Fiscal year 2010: $0.36 per share | Fiscal year 2009: $1.54 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: